VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
DOX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
DOXAmdocs Limited
$42.09$4.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksDOXCash Flow

Amdocs Limited (DOX) Cash Flow Statement

30Y historyFree accessUpdated daily

Free cash flow generation remains resilient with a 14.6% margin in the latest quarter, but operating cash flow is heavily influenced by volatile working capital swings, such as the $72.1M source in 2026Q3 versus a -$137.3M use in the prior quarter.

Income StatementBalance SheetCash FlowRatios

DOX Cash Flow Statement

Annual statement

DOX Cash Flow Statement

Amdocs Limited (DOX) cash flow statement — 30-year operating, investing & financing cash flows

AnnualQuarterly
MetricSep'26Sep'25Sep'24Sep'23Sep'22Sep'21Sep'20Sep'19Sep'18Sep'17Sep'16Sep'15Sep'14Sep'13Sep'12Sep'11Sep'10Sep'09Sep'08Sep'07Sep'06Sep'05Sep'04Sep'03Sep'02Sep'01Sep'00Sep'99Sep'98Sep'97
Cash from Operations672.72M749.1M724.43M822.63M756.72M925.81M658.14M656.38M557.25M636.11M620.23M772.62M709.26M670.55M514.07M535.49M685.2M519.16M483.62M424M429.22M381.75M344.4M381.97M412.28M337.99M287.59M152.3M66.5M25.9M
Operating CF Margin %14.32%16.53%14.47%16.83%16.53%21.59%15.79%16.06%14.02%16.45%16.68%21.21%19.9%20.04%15.83%16.85%22.96%18.14%15.29%14.95%17.31%18.73%19.42%25.75%25.55%22.03%25.72%24.29%16.47%8.93%
Operating CF Growth %-10.2%3.41%-11.94%8.71%-18.26%40.67%0.27%17.79%-12.4%2.56%-19.72%8.93%5.77%30.44%-4%-21.85%31.98%7.35%14.06%-1.22%12.43%10.84%-9.84%-7.35%21.98%17.52%88.83%129.02%156.76%-
Net Income501.24M567.77M496.32M542.96M549.5M688.37M497.84M479.45M354.4M436.83M409.33M446.16M422.12M412.44M391.37M346.67M343.91M326.18M378.91M364.94M318.64M288.64M234.86M168.88M-5.06M66.39M5.98M98.5M30.4M5.9M
Depreciation & Amortization210.36M195.44M193.07M195.7M224.53M208.83M198.41M205.77M211.22M214.88M211.79M174.79M162.77M140.78M159.61M181.48M195.94M198.12M192.94M164.99M117.9M93.83M100.88M97.45M309.82M282.63M155.36M30.6M29.1M8.4M
Stock-Based Compensation0104.86M104.54M89.7M71.81M54.25M42.43M38.55M47.48M44.54M42.7M44.56M44.58M40.34M43.43M36.63M44.45M42.91M000000000000
Deferred Taxes35.5M20.29M-45.67M-60.21M-3.29M-50.6M30.24M-13.95M21.4M6.55M-2.31M-26.89M-6.51M12.48M-4.86M1.25M-22.23M16.25M1.11M-21.09M22.81M8.06M-11.27M4M-1.67M5.02M-1.2M-4M-2M-11.9M
Other Non-Cash Items105.69M4.09M6.17M3.34M-6.71M-224.14M144K737K-2.51M-4.66M-6.51M-5.47M-2.9M1.9M-6.31M1.21M22.39M8.08M59.06M53.54M71.18M4.46M3.51M9.45M33.21M3.92M84.6M200K-1.4M1.8M
Working Capital Changes-180.06M-143.36M-30M51.14M-79.12M249.09M-110.93M-54.18M-74.74M-62.03M-34.77M139.46M89.2M62.6M-69.18M-31.74M100.74M-72.38M-152.97M-135.44M-98.07M-13.24M16.43M102.19M75.97M-19.96M42.85M26M10.6M21.7M
Change in Receivables-193.36M79.61M-104.41M3.46M-64.98M-69.05M134.58M6.59M-67.2M-41.08M-70.86M39.83M5.54M30M-106.55M38.06M-131.39M131.53M000000000000
Change in Inventory00000-7.36M-32.09M37.13M-48.82M-42.78M25.94M33.31M11.68M51.79M32.99M000000000000000
Change in Payables61.01M-77.04M216.32M158.88M-83.93M122.22M-190.35M-60.04M25.35M72.05M59.98M63.89M73.95M-4.1M60.2M000000000000000
Cash from Investing-315.07M-2.06M-127.41M-224.5M-262.5M-329M-461.73M-86.76M-362.39M-185.31M-440.85M-379.65M-298.55M-297.13M-17.29M-221.67M-211.51M-66.38M-169.71M-441.28M-629.24M-126.16M-260.21M47.01M-653.63M-339.19M-2.67M-41.7M-25.7M-49.1M
Capital Expenditures-110.53M-103.95M-105.5M-124.36M-227.22M-210.44M-205.51M-128.09M-231.15M-133.39M-130.09M-120.5M-111.57M-106.72M-122.05M-109.78M-86.94M-83.33M-135.82M-166.43M-80.72M-71.37M-54.15M-62.41M-58.56M-91.89M-56.57M-42.2M-26.6M-49.1M
CapEx % of Revenue2.35%2.29%2.11%2.54%4.96%4.91%4.93%3.13%5.82%3.45%3.5%3.31%3.13%3.19%3.76%3.45%2.91%2.91%4.3%5.87%3.25%3.5%3.05%4.21%3.63%5.99%5.06%6.73%6.59%16.93%
Acquisitions-218.64M-86.32M-86.82M-121.82M-14.43M146.29M-249.36M-60.57M-355.14M-18.06M-283.45M-263.19M-180.54M-112.41M122.05M-162.96M-200.31M-65.89M-58.77M-90.72M-624.8M-262.25M-10.65M-30.98M-213.18M00000
Investments------------------------------
Other Investing14.1M18.21M5.32M-4.3M-8.53M-6.08M-6.1M615K-3.16M-29.94M-18.53M1.41M3.87M-2.8M-130.62M-18.08M22.01M994K2.65M3.83M4.27M5.83M4.43M2.53M-39.58M-10.23M53.9M500K900K0
Cash from Financing-485.6M-768.12M-771.02M-651.43M-629.9M-870.93M315.14M-516.77M-425.69M-569.85M-446.3M-460.66M-321.63M-238.38M-448.99M-518.64M-166.26M-442.87M-210.56M25.6M99.66M-98.39M-381.44M-48.04M-164.99M471.9M32.21M-50.8M-69.1M60.9M
Debt Issued (Net)300M0000-100M743.92M00-200M-20M10M10M0-50M49.12M199.38M-450.75M-717K-25K-7.92M-22.44M14.01M-58.44M-60.87M457.93M10.85M-93.3M78.9M-12.9M
Equity Issued (Net)-503.53M-530.05M-563.12M-489.52M-508.47M-590.94M-360.91M-398.06M-337.95M-253.01M-323.82M-454.02M-372.01M-367.06M-484.61M-624.24M-389.29M-20.01M-210.05M24.83M106.85M-75.95M-395.45M2.32M-104.12M13.97M21.36M42.5M330.6M91.7M
Dividends Paid-233.69M-224.39M-211.97M-199.46M-186.07M-177.47M-164.06M-147.62M-134.29M-121.5M-109.3M-100.79M-90.94M-84.01M00000000000000-478.7M-18M
Share Repurchases-510.51M-551.34M-563.12M-489.52M-508.47M-680M-360.91M-398.06M-419.23M-340.6M-413.42M-454.02M-372.01M-367.06M-484.61M-624.24M-389.29M-20.01M-247.63M-49.84M0-99.98M-407.53M0-109.28M00000
Other Financing-48.38M-13.68M4.07M37.55M64.64M-2.52M96.2M28.9M46.55M4.67M6.83M84.15M131.32M212.69M85.61M56.47M23.64M27.89M211K795K722K008.08M0000100K100K
Net Change in Cash-127.95M-21.09M-174M-53.3M-135.69M-274.12M511.56M52.85M-230.83M-119.05M-266.91M-67.7M89.08M135.03M47.79M-204.82M307.43M9.91M103.35M8.31M-100.36M157.2M-297.25M380.94M-406.34M470.7M317.13M59.8M-28.3M60.9M
Free Cash Flow562.2M645.14M618.93M698.27M529.5M715.37M452.63M528.29M326.1M502.72M490.15M652.12M597.69M563.82M392.02M425.71M598.25M435.83M347.8M257.57M348.5M310.38M290.26M319.56M353.71M246.1M231.02M110.1M39.9M-23.2M
FCF Margin %11.97%14.23%12.37%14.29%11.57%16.68%10.86%12.93%8.2%13%13.18%17.9%16.77%16.85%12.07%13.4%20.05%15.22%11%9.08%14.05%15.22%16.36%21.54%21.92%16.04%20.66%17.56%9.88%-8%
FCF Growth %-12.86%4.23%-11.36%31.87%-25.98%58.05%-14.32%62%-35.13%2.56%-24.84%9.11%6.01%43.83%-7.92%-28.84%37.27%25.31%35.03%-26.09%12.28%6.93%-9.17%-9.66%43.73%6.53%109.82%175.94%271.98%-
FCF per Share5.295.775.435.894.345.593.403.852.273.413.244.163.703.462.312.282.932.101.581.151.591.431.321.451.611.081.060.550.25-0.12
FCF Conversion (FCF/Net Income)1.34x1.33x1.47x1.52x1.38x1.34x1.32x1.37x1.57x1.46x1.52x1.73x1.68x1.63x1.31x1.54x1.99x1.59x1.28x1.16x1.35x1.32x1.47x2.26x-81.46x5.09x48.11x1.55x2.21x4.39x
Interest Paid041.47M35.4M19.43M16.74M19.37M5.39M7.35M2.01M1.15M576K548K628K468K408K433K2.85M3.32M4.86M00000000000
Taxes Paid0122.42M187.51M156.39M80.42M146.44M45.4M75.79M55.94M67.54M50.41M51.14M59.22M38.44M36.91M19.61M46.45M39.79M51.27M00000000000

Key Metrics

Growth RegimeDecelerating
ProfitabilityModerate
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Sustained revenue contraction in core vertical

Earnings Quality Masked by Working Capital Volatility

The volatile relationship between net income and operating cash flow, with OCF/NI ratios swinging from 0.70 to 3.17 over the past ten quarters, suggests that reported earnings are heavily influenced by non-cash accruals and working capital timing rather than pure operational cash generation.

The significant divergence in the latest quarter, where operating cash flow of $197.2M was 3.17 times net income of $62.2M, appears driven by a large $72.1M favorable working capital swing. This pattern indicates that the quality of earnings is inconsistent and heavily dependent on the timing of collections and project milestones, a characteristic risk of percentage-of-completion accounting. Investors should monitor whether this conversion strength is sustainable or merely reflects a one-time release of previously accrued amounts.

FCF Resilience Amidst Top-Line Contraction

Despite a sustained -9.4% YoY revenue decline, Amdocs has maintained robust free cash flow margins, averaging 13.3% over the last four quarters, indicating that its cost structure and capital discipline are effectively protecting cash generation during a period of demand softness.

The FCF margin of 14.6% in the most recent quarter, while down from the 18.5% peak in 2025Q3, remains healthy and demonstrates the defensive nature of the managed services revenue base. This resilience suggests that the company's core operations are generating substantial cash even as project-based revenue lags. However, the trajectory shows a clear deceleration from the high-teens margins seen in late 2025, which may indicate that the benefits of cost discipline are beginning to wane against persistent revenue headwinds.

Working Capital Swings Drive Cash Flow Volatility

Working capital changes have been the primary driver of quarterly operating cash flow volatility, with swings from a -$137.3M use in 2026Q2 to a $72.1M source in 2026Q3, highlighting the lumpy cash conversion cycle inherent in large-scale project-based contracts.

The erratic pattern in working capital, with significant negative swings in quarters like 2025Q1 (-$121.7M) and 2026Q2 (-$137.3M), suggests that collections and project billing are not evenly distributed. This volatility obscures the underlying operational cash generation and makes quarterly FCF less predictable. The recent positive swing in 2026Q3 may represent a catch-up in collections, but the lack of a consistent trend warrants close monitoring for potential future cash flow disruptions.

Consistent Capital Returns Despite Earnings Pressure

Amdocs has maintained a steady and significant return of capital to shareholders, with quarterly dividends and buybacks consistently totaling over $200M, even as net income has declined, suggesting a commitment to shareholder returns that may be prioritized over balance sheet accumulation.

The company has returned an average of $202M per quarter via dividends and buybacks over the last four periods, a level that appears sustainable given the strong FCF generation. This consistent deployment, particularly the aggressive buyback program, indicates management's confidence in the long-term cash flow durability of the business. However, the recent $194.5M acquisition in 2026Q1, followed by minimal activity, suggests a pause in M&A, possibly due to the uncertain demand environment or a focus on integrating prior deals.

Cash Flow Statement Obscures True Cost of Growth

The cash flow statement does not fully capture the economic cost of stock-based compensation, which averaged $27.3M per quarter, nor does it reflect the potential future cash obligations embedded in the company's large, long-term managed services contracts.

While SBC is added back to calculate operating cash flow, it represents a real dilutive cost to shareholders that is not reflected in the FCF figure. Furthermore, the percentage-of-completion accounting method can lead to revenue recognition ahead of cash collections, creating a potential mismatch between reported performance and actual cash inflows. The significant unbilled receivables and deferred revenue balances, which are not detailed in the provided data, could further obscure the true timing of cash flows relative to economic activity.

DOX — Frequently Asked Questions

Quick answers to the most common questions about buying DOX stock.

How much cash does Amdocs Limited (DOX) generate from operations?

Amdocs Limited (DOX) generated $672.7M in net cash from operating activities in 2026. This reflects the cash generated directly from core business operations.

What is Amdocs Limited's free cash flow?

Amdocs Limited (DOX) generated $562.2M in free cash flow in 2026. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Amdocs Limited's capital expenditure (CapEx)?

Amdocs Limited (DOX) spent $110.5M on capital expenditures in 2026. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Amdocs Limited distribute cash to shareholders?

In 2026, Amdocs Limited (DOX) returned $233.7M to shareholders via cash dividends and spent $510.5M on share repurchases. This shows the company's commitment to returning capital to its equity investors.